Psyadon Pharmaceuticals

Acquired

Developing ecopipam, a dopamine D-1 antagonist, for the treatment of Tourette's syndrome, a neurological disorder manifested by motor and phonic tics.

Psyadon Pharmaceuticals is a biotech company in Germantown, United States, founded in 2004. It has raised $8.0M across 2 rounds, most recently a Venture Round in August 2018.

Employees
1–10
Founded
2004
Business Model
B2B
Total Funding
$8.0M
Last Round
Venture RoundAug 2018
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 3 investors for this company. to use credits for reveals, or explore the API.

About

Psyadon Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing treatments for rare and serious neurological disorders, most notably Tourette syndrome. The company has conducted clinical trials for ecopipam, a selective dopamine D1/D5 receptor antagonist being investigated as a potential treatment for Tourette syndrome in both pediatric and adult populations. Based in Germantown, Maryland, Psyadon operates as a small, focused drug development organization targeting underserved CNS conditions where current treatment options remain limited.

Funding History

Data from Indexed.vcUpdated
Venture RoundVenture RoundAug 2018

1 more funding event

  • Series A20083 investors

Funding: Series A through Venture Round. Amounts, valuations, and investors where available.

Investors

Companies in related industries

Neuralink

Neuralink develops investigational implantable brain-computer interfaces that help people with pa...

Fremont, United States201–500Biotech
Series ETotal funding$1.2BJun 2025
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Psyadon Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/psyadon-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/psyadon-pharmaceuticals" alt="Psyadon Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>